If any more evidence were needed of a bounceback in venture financing for biotechs after a dip in 2023, the $400 million first round just announced by Mirador Therapeutics should suffice.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We’ll have more to share soon on The Bread Club. The tomato soup at the flagship Mirador in downtown Dallas will appear on the menu at Mirador Cafe in Fort Worth when it opens in 2025.